CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 12,000 shares at an average $81.62 ($979,480)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 4,000 shares at $64.25 ($257,000)
- 144 Insider Sale of Securities
- 4 Gift President and CEO gave 620 shares (gift)
- 4 Planned sale Director sold 4,000 shares at $59.25 ($237,000)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 10,415 shares at $54.78 ($570,534)
- 4 Open-market sale President and CEO sold 52,444 shares at an average $54.92 ($2,880,044)
- 144 Insider Sale of Securities
- 4 Gift President and CEO gave 5,000 shares (gift)
- 8-K Event Shareholder vote results
- 4 Gift President and CEO gave 1,355 shares (gift)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Medical Officer sold 20,000 shares at an average $56.27 ($1,125,400)
Page 6 of 36 · 707 filings